优化资源:低剂量尼沃卢马布组合治疗复发性/耐药霍奇金淋巴瘤
Perla R Colunga-Pedraza1, Héctor A Vaquera-Alfaro1,2, Zulia Guzmán-Martínez1,2
1Servicio de Hematología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
Annals of hematology
|November 19, 2024
概括
低剂量尼沃卢马布在复发/耐药的古典霍奇金淋巴瘤 (cHL) 中显示出有希望的疗效,提供潜在的成本效益治疗. 这种方法在单中心研究中实现了高响应率和有利的生存结果.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 经典霍奇金淋巴瘤 (cHL) 经常涉及治疗耐药性或复发.
- 免疫检查点抑制剂 (ICI) 对复发性/耐药性cHL (r/r cHL) 有效,但可能昂贵.
- 新出现的数据表明,低剂量ICI可能与标准剂量具有相似的疗效.
研究的目的:
- 评估低剂量尼沃卢马布 (LD-Nivo) 在患有r/rcHL的患者的疗效和安全性.
- 为了评估LD-Nivo在各种组合:单疗法,与布伦图西马布维多丁 (BV),和化疗.
- 探索LD-Nivo作为一个具有成本效益的治疗策略的潜力.
主要方法:
- 一个单一中心的回顾性研究包括23名连续患有r/rcHL的患者.
- 患者每两周接受一次固定剂量 (40,100或140毫克) 的LD-Nivo.
- 通过使用卡普兰-梅尔分析,通过整体响应率 (ORR),完整响应 (CR),部分响应 (PR),整体存活率 (OS) 和无进展存活率 (PFS) 来评估有效性.
主要成果:
- 观察到的整体响应率为73%,其中43%达到CR,30%达到PR.
- 一年后的OS为94.4%,一年后的PFS为89.4%.
- 不同的LD-Nivo组合或剂量之间没有发现生存或反应的显著差异;不良事件通常是低级的.
结论:
- 低剂量尼沃卢马布在r/rcHL中显示出令人鼓舞的疗效和安全性.
- 在各种组合中,LD-Nivo为标准剂量ICI提供了潜在的成本效益替代品.
- 需要进一步的研究来证实这些发现,并为临床实践提供信息.
更多相关视频
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


